SYNGAP1 Foundation

SYNGAP1 Foundation is a leading research and advocacy organization dedicated to serving, educating, and funding crucial research for families navigating the complexities of SYNGAP1 mutations. With a global reach, SYNGAP1 Foundation holds the largest SYNGAP1 Natural History Study (NHS) and Patient database worldwide, making them a pivotal resource in understanding and addressing this condition.

Located at 1012 14th St NW, 500, Washington, District of Columbia 20005, US, SYNGAP1 Foundation is at the forefront of advancing knowledge related to SYNGAP1. Their mission extends to overlapping neurological diseases and mental illnesses linked to the SynGAP protein, such as Alzheimer’s, Parkinson’s, and Schizophrenia. Through dedicated research and advocacy, SYNGAP1 Foundation strives to improve the lives of those affected by these conditions.

Driven by a commitment to policy, autism advocacy, research, epilepsy solutions, healthcare improvements, awareness campaigns, and education, SYNGAP1 Foundation plays a critical role in the global healthcare landscape. We invite the management team at SYNGAP1 Foundation to create a customized and exclusive company showcase and product listing on our platform to further amplify their reach and impact.